Evidence map›Paper›PMID 34996643›Full record

ArticleVaccine2022

International links between Streptococcus pneumoniae vaccine serotype 4 sequence type (ST) 801 in Northern European shipyard outbreaks of invasive pneumococcal disease.

R A Gladstone, L Siira, O B Brynildsrud, D F Vestrheim, P Turner, S C Clarke, S Srifuengfung, R Ford, D Lehmann, E Egorova and 12 more

Abstract read
In one paragraph

Article in Vaccine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Increase in serotypes 4 and 14 in invasive pneumococcal disease in adults aged 18 to 59 years. A retrospective population-based descriptive study during the period 2007-2025 in the Community of Madrid, Spain.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  4. Review
  5. Digital PCR linkage analysis resolvesMicrobiology spectrum · 2026
    Article
  6. Single-cell sequencing: accurate disease detection.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  7. Article
  8. ThirdEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2025
    Article
  9. Article
  10. Article
  11. Streamlining marker-less allelic replacement inApplied and environmental microbiology · 2024
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Invasive pneumococcal disease surveillance in Canada, 2020.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

R A GladstoneDepartment of Biostatistics, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway; Parasites and Microbes, Wellcome Sanger Institute, Cambridge, UK.
L SiiraDepartment of Health Security, Finnish Institute for Health and Welfare (THL), Helsinki, Finland.
O B BrynildsrudDivision of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway.
D F VestrheimDivision of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway.
P TurnerCentre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK; Cambodia Oxford Medical Research Unit, Angkor Hospital for Children, Siem Reap, Cambodia.
S C ClarkeFaculty of Medicine and Institute of Life Sciences, University of Southampton, UK; NIHR Southampton Biomedical Research Centre, University Hospital Southampton NHS Trust, Southampton, United Kingdom; Global Health Research Institute, University of Southampton, Southampton, United Kingdom; School of Postgraduate Studies, International Medical University, Kuala Lumpur, Malaysia; Centre for Translational Research, IMU Institute for Research, Development and Innovation (IRDI), Kuala Lumpur, Malaysia.
S SrifuengfungFaculty of Pharmacy, Siam University, Bangkok, Thailand.
R FordPapua New Guinea Institute of Medical Research, PO Box 60, Goroka 441, Eastern Highlands Province, Papua New Guinea.
D LehmannTelethon Kids Institute, the University of Western Australia, Perth, WA, Australia.
E EgorovaG.N. Gabrichevsky Research Institute for Epidemiology and Microbiology, Moscow, Russia.
E VoropaevaG.N. Gabrichevsky Research Institute for Epidemiology and Microbiology, Moscow, Russia.
G HaraldssonDepartment of Clinical Microbiology, Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland and Faculty of Medicine, University of Iceland.
K G KristinssonDepartment of Clinical Microbiology, Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland and Faculty of Medicine, University of Iceland.
L McGeeCenters for Disease Control and Prevention, Atlanta, USA.
R F BreimanEmory Global Health Institute, Atlanta, USA; Rollins School Public Health, Emory University, USA.
S D BentleyParasites and Microbes, Wellcome Sanger Institute, Cambridge, UK.
C L SheppardVaccine Preventable Bacteria Section, Public Health England - National Infection Service, London, United Kingdom.
N K FryVaccine Preventable Bacteria Section, Public Health England - National Infection Service, London, United Kingdom; Immunisation and Countermeasures Division, Public Health England - National Infection Service, London, United Kingdom.
J CoranderDepartment of Biostatistics, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway; Parasites and Microbes, Wellcome Sanger Institute, Cambridge, UK.
M ToropainenDepartment of Health Security, Finnish Institute for Health and Welfare (THL), Helsinki, Finland.
A SteensDivision of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway.
Global Pneumococcal Sequencing Consortium

Funding

Gates Foundation INV-003570Medical Research Council MR/R015600/1Wellcome TrustWellcome Trust 202101Wellcome Trust 206194/Z/17/Z
6 · The paper itself

Abstract

backgroundPneumococcal disease outbreaks of vaccine preventable serotype 4 sequence type (ST)801 in shipyards have been reported in several countries. We aimed to use genomics to establish any international links between them.

methodsSequence data from ST801-related outbreak isolates from Norway (n = 17), Finland (n = 11) and Northern Ireland (n = 2) were combined with invasive pneumococcal disease surveillance from the respective countries, and ST801-related genomes from an international collection (n = 41 of > 40,000), totalling 106 genomes. Raw data were mapped and recombination excluded before phylogenetic dating.

resultsOutbreak isolates were relatively diverse, with up to 100 SNPs (single nucleotide polymorphisms) and a common ancestor estimated around the year 2000. However, 19 Norwegian and Finnish isolates were nearly indistinguishable (0-2 SNPs) with the common ancestor dated around 2017.

conclusionThe total diversity of ST801 within the outbreaks could not be explained by recent transmission alone, suggesting that harsh environmental and associated living conditions reported in the shipyards may facilitate invasion of colonising pneumococci. However, near identical strains in the Norwegian and Finnish outbreaks does suggest that transmission between international shipyards also contributed to those outbreaks. This indicates the need for improved preventative measures in this working population including pneumococcal vaccination.

Indexed as

Pneumococcal InfectionsStreptococcus pneumoniaeDisease OutbreaksFinlandGenome, BacterialHumansNorthern IrelandNorwayOccupational ExposurePhylogenyPolymorphism, Single NucleotideSerogroupSerotypingShipsMolecular epidemiologyOutbreakPCVsPneumococcalPPV23Serotype 4ST801Streptococcus pneumoniaeWhole genome sequencing

Identifiers

PMID34996643
PMCPMC8820377

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.